DnB Asset Management
CVS icon

DnB Asset Management’s CVS Health CVS Stock Holding History

DnB Asset Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.4M Buy
506,583
+59,740
+13% +$4.6M 0.13% 123
2025
Q4 		$35.5M Buy
446,843
+66,953
+18% +$5.28M 0.12% 114
2025
Q3 		$28.6M Buy
379,890
+151,934
+67% +$10.4M 0.11% 144
2025
Q2 		$15.7M Buy
227,956
+6,621
+3% +$434K 0.07% 196
2025
Q1 		$15M Buy
221,335
+1,961
+0.9% +$117K 0.07% 195
2024
Q4 		$9.85M Buy
219,374
+11,483
+6% +$644K 0.04% 263
2024
Q3 		$13.1M Buy
207,891
+5,140
+3% +$300K 0.06% 216
2024
Q2 		$12M Buy
202,751
+13,027
+7% +$815K 0.06% 204
2024
Q1 		$15.1M Sell
189,724
-122,059
-39% -$9.32M 0.08% 182
2023
Q4 		$24.6M Sell
311,783
-61,513
-16% -$4.38M 0.13% 132
2023
Q3 		$26.1M Buy
373,296
+15,683
+4% +$1.11M 0.16% 114
2023
Q2 		$24.7M Buy
357,613
+4,240
+1% +$302K 0.14% 123
2023
Q1 		$26.3M Sell
353,373
-2,428
-0.7% -$204K 0.17% 117
2022
Q4 		$33.2M Buy
355,801
+21,837
+7% +$2.11M 0.23% 98
2022
Q3 		$31.9M Buy
333,964
+1,685
+0.5% +$167K 0.25% 92
2022
Q2 		$30.8M Sell
332,279
-2,914
-0.9% -$284K 0.22% 106
2022
Q1 		$33.9M Buy
335,193
+10,530
+3% +$1.11M 0.2% 102
2021
Q4 		$33.5M Buy
324,663
+15,999
+5% +$1.48M 0.2% 103
2021
Q3 		$26.2M Sell
308,664
-2,253
-0.7% -$189K 0.17% 113
2021
Q2 		$25.9M Buy
310,917
+111,745
+56% +$9.15M 0.17% 113
2021
Q1 		$15M Buy
199,172
+15,258
+8% +$1.11M 0.11% 148
2020
Q4 		$12.6M Buy
183,914
+989
+0.5% +$64.3K 0.11% 151
2020
Q3 		$10.7M Buy
182,925
+9,975
+6% +$621K 0.11% 139
2020
Q2 		$11.2M Sell
172,950
-20,616
-11% -$1.3M 0.13% 128
2020
Q1 		$11.5M Sell
193,566
-138,996
-42% -$9.28M 0.17% 111
2019
Q4 		$24.7M Buy
332,562
+165,671
+99% +$11.6M 0.24% 77
2019
Q3 		$10.5M Buy
166,891
+10,530
+7% +$624K 0.12% 138
2019
Q2 		$8.52M Sell
156,361
-4,858
-3% -$262K 0.1% 163
2019
Q1 		$8.69M Sell
161,219
-12,376
-7% -$764K 0.1% 151
2018
Q4 		$11.4M Sell
173,595
-1,117,520
-87% -$83.4M 0.15% 120
2018
Q3 		$102M Buy
1,291,115
+63,178
+5% +$4.52M 1.14% 21
2018
Q2 		$79M Sell
1,227,937
-118,700
-9% -$7.82M 0.93% 25
2018
Q1 		$83.8M Buy
1,346,637
+88,400
+7% +$6.34M 1.01% 24
2017
Q4 		$91.2M Buy
1,258,237
+1,129,044
+874% +$82.1M 1.1% 22
2017
Q3 		$10.5M Sell
129,193
-251,100
-66% -$19.9M 0.14% 114
2017
Q2 		$30.6M Sell
380,293
-51,467
-12% -$4.06M 0.45% 54
2017
Q1 		$33.9M Sell
431,760
-67,005
-13% -$5.35M 0.53% 43
2016
Q4 		$39.4M Sell
498,765
-151,100
-23% -$12.2M 0.72% 34
2016
Q3 		$57.8M Buy
649,865
+396,000
+156% +$37.4M 1.14% 24
2016
Q2 		$24.3M Sell
253,865
-17,820
-7% -$1.78M 0.52% 51
2016
Q1 		$28.2M Buy
271,685
+48,000
+21% +$4.67M 0.59% 47
2015
Q4 		$21.9M Buy
223,685
+1,900
+0.9% +$186K 0.47% 51
2015
Q3 		$21.4M Buy
221,785
+12,887
+6% +$1.35M 0.53% 48
2015
Q2 		$21.9M Buy
208,898
+21,200
+11% +$2.17M 0.48% 55
2015
Q1 		$19.4M Buy
187,698
+27,868
+17% +$2.82M 0.43% 57
2014
Q4 		$15.4M Buy
159,830
+15,837
+11% +$1.4M 0.35% 60
2014
Q3 		$11.5M Buy
143,993
+12,700
+10% +$1M 0.25% 76
2014
Q2 		$9.9M Buy
+131,293
New +$9.92M 0.21% 91
2013
Q4 		$12.7M Buy
177,593
+55,800
+46% +$3.59M 0.3% 74
2013
Q3 		$6.91M Buy
121,793
+28,100
+30% +$1.67M 0.19% 86
2013
Q2 		$5.36M Buy
+93,693
New +$5.43M 0.16% 86

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DnB Asset Management's CVS Position: Q1 2026 in Review

DnB Asset Management increased its CVS Health (CVS) stake by 13% in Q1 2026, buying an estimated $4.6M and bringing the position to 506,583 shares worth $36.4M. The position accounts for 0.13% of the portfolio, ranked #123.

DnB Asset Management first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $102M in Q3 2018. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • DnB Asset Management held 506,583 shares of CVS Health worth $36.4M as of Q1 2026.
  • DnB Asset Management bought 59,740 CVS Health shares in Q1 2026, an estimated $4.6M.
  • CVS Health made up 0.13% of DnB Asset Management's portfolio in Q1 2026, its #123 holding.
  • DnB Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • DnB Asset Management's CVS Health position peaked at $102M in Q3 2018.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.